Study protocol for a phase 2A trial of the safety and tolerability of increased dose rifampicin and adjunctive linezolid, with or without aspirin, for HIV-associated tuberculous meningitis [LASER-TBM]

MLA

Paolo Denti, et al. “Study Protocol for a Phase 2A Trial of the Safety and Tolerability of Increased Dose Rifampicin and Adjunctive Linezolid, with or without Aspirin, for HIV-Associated Tuberculous Meningitis [LASER-TBM].” Wellcome Open Research, vol. 6, June 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ae9acabc4223687951e70ea4d6392f54&authtype=sso&custid=ns315887.

APA

Paolo Denti, John A. Joska, Gerda Wahl, Shiraz Moosa, John H. Black, Robert J. Wilkinson, Louise Lai Sai, Marise Bremer, Ernesta M. Meintjes, Graeme Meintjes, Sally Candy, Patryk Szymanski, Saalikha Aziz, Lori E. Dodd, Rene Goliath, Frances Robertson, Cari Stek, Ismail Banderker, Anna J. Dreyer, … Curtis Offiah. (2021). Study protocol for a phase 2A trial of the safety and tolerability of increased dose rifampicin and adjunctive linezolid, with or without aspirin, for HIV-associated tuberculous meningitis [LASER-TBM]. Wellcome Open Research, 6.

Chicago

Paolo Denti, John A. Joska, Gerda Wahl, Shiraz Moosa, John H. Black, Robert J. Wilkinson, Louise Lai Sai, et al. 2021. “Study Protocol for a Phase 2A Trial of the Safety and Tolerability of Increased Dose Rifampicin and Adjunctive Linezolid, with or without Aspirin, for HIV-Associated Tuberculous Meningitis [LASER-TBM].” Wellcome Open Research 6 (June). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ae9acabc4223687951e70ea4d6392f54&authtype=sso&custid=ns315887.